Impact of hepatic immunoreactivity of angiotensin-converting enzyme 2 on liver fibrosis due to non-alcoholic steatohepatitis-Reference-Cited by-同舟云学术

Impact of hepatic immunoreactivity of angiotensin-converting enzyme 2 on liver fibrosis due to non-alcoholic steatohepatitis

Published:2015-12 Issue:6 Volume:39 Page:692-698
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Cengiz Mustafa,Ozenirler Seren,Yılmaz Guldal,Erkan Gulbanu

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Human fatty liver disease: old questions and new insights;Cohen;Science,2011

2. An overview of nonalcoholic steatohepatitis: past, present and future directions, Journal of gastrointestinal and liver diseases;Pascale;J Gastrointestin Liver Dis,2010

3. Prevalence, gender, ethnic variations, and prognosis of NASH;Hashimoto;J Gastroenterol,2011

4. Steatohepatitis: a tale of two “hits”?;Day;Gastroenterology,1998

5. Molecular mediators of hepatic steatosis and liver injury;Browning;J Clin Invest,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Burden of Nonalcoholic Steatohepatitis: A Systematic Review of Epidemiology Studies;Gastro Hep Advances;2022

2. Deciphering the cellular mechanisms underlying fibrosis-associated diseases and therapeutic avenues;Pharmacological Research;2021-01

3. Balance and circumstance: The renin angiotensin system in wound healing and fibrosis;Cellular Signalling;2018-11

4. Loss of angiotensin converting enzyme II (ACE2) accelerates the development of liver injury induced by thioacetamide;Experimental Animals;2018

5. The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research;Current Drug Targets;2017-08-10